These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10331044)

  • 1. Plasma endothelin in cyclosporine A-treated renal transplant patients.
    Grekas D; Bamichas G; Karamouzis M; Bacharaki D; Savidis N; Tourkantonis A
    Transplant Proc; 1999 May; 31(3):1703-5. PubMed ID: 10331044
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelin-1 plasma levels in cyclosporine-treated stable renal transplant patients.
    Costa C; Cauduro RL; Lhulier F; Cabral RD; Garcia RG; Manfro RC
    Transplant Proc; 2002 Mar; 34(2):487-8. PubMed ID: 12009599
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 4. A retrospective analysis of Neoral C2 monitoring in Chinese renal transplantation recipients.
    Tan J; Tang X
    Transplant Proc; 2003 Feb; 35(1):232-3. PubMed ID: 12591377
    [No Abstract]   [Full Text] [Related]  

  • 5. Conventional versus Neoral cyclosporine in renal transplantation.
    Rovelli E; Bucci A; Maldifassi P; Belfiore A; D'Amico G
    Transplant Proc; 1998 Aug; 30(5):1764-5. PubMed ID: 9723272
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients.
    Varghese Z; Abudher MN; Fernando ON; Moorhead JF
    Transplant Proc; 2001 May; 33(3):2251-3. PubMed ID: 11377518
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical study of sandimmun neoral in cadaveric renal transplantation.
    Xue W; Chen Y; Xing J; Tian P
    Transplant Proc; 1996 Jun; 28(3):1333-4. PubMed ID: 8658682
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
    Griffin PJ; Moore RH; Jurewicz WA; Lord RH; Webley Y; Jenkins J
    Transplant Proc; 1997; 29(1-2):303. PubMed ID: 9123007
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of grapefruit juice on serum concentration of cyclosporine in Iranian renal transplant patients.
    Mehrsai AR; Pourmand G; Mansour D; Zand S; Rezaali A
    Transplant Proc; 2003 Nov; 35(7):2739-41. PubMed ID: 14612100
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method.
    First MR; Weiskittel P; Burton M; Shah M; Dreyer D; Fleck P; Bey C; Peddi R; Canafax D; Schroeder TJ
    Transplant Proc; 1998 Aug; 30(5):1701-5. PubMed ID: 9723249
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with high-dose folic acid effectively lowers plasma homocysteine concentration in cyclosporine-treated renal transplant recipients.
    Arnadottir M; Hultberg B
    Transplantation; 1997 Oct; 64(7):1087. PubMed ID: 9381536
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of nicardipine on blood cyclosporine levels in renal transplant patients.
    Guan D; Wang R; Lu J; Wang M; Xu C
    Transplant Proc; 1996 Jun; 28(3):1311-2. PubMed ID: 8658673
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of kidney functions and cyclosporine levels in renal transplant patients on Panimum Bioral in post transplant period.
    Sharma DR; Singh S
    J Indian Med Assoc; 1999 May; 97(5):204-5. PubMed ID: 10652891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of cyclosporine exposure utilizing C(2) level monitoring in de novo renal transplant recipients: the Toronto General Hospital experience.
    Maham N; Cardella C; Cattran D; Fenton S; O'Grady C; Hamill J; Smith R; Cole E
    Transplant Proc; 2001; 33(7-8):3098-9. PubMed ID: 11750331
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression.
    Asberg A; Attramadal H; Midtvedt K; Sund S; Hartmann A; Berg KJ
    Transplantation; 1999 Apr; 67(7):1056-60. PubMed ID: 10221493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
    Rial MC; Frias S; Argento J; Tessler J; Casadei D
    Transplant Proc; 1997; 29(1-2):292-3. PubMed ID: 9123001
    [No Abstract]   [Full Text] [Related]  

  • 17. Polyclonal/monoclonal ratio in kidney and bone marrow transplanted patients treated with cyclosporine.
    Capone D; De Marino V; Caso N; Stanziale P; Fontana R; Imperatore P; De Marino V; Pisanti N
    Clin Transplant; 1998 Oct; 12(5):430-3. PubMed ID: 9787953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine does not influence serum cholesterol in kidney transplant recipients.
    Matzkies FK; Keuthage W; Kobelt V; Hillebrand U; Gerhardt U; Suwelack B; Hohage H
    Transplant Proc; 2002 Aug; 34(5):1795-6. PubMed ID: 12176580
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
    Cossu M; Satta R; Branca GF; Pala PG; Serra G; Satta RP; Sorba G
    Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271
    [No Abstract]   [Full Text] [Related]  

  • 20. Sandimmun and Neoral treatment: pharmacokinetics and kidney function in paediatric and adolescent renal transplant.
    De Palma MT; Giordano M; Colella V; Palumbo F; De Nicolo VE; Caringella DA
    Transplant Proc; 1998 Aug; 30(5):1677. PubMed ID: 9723239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.